Circulating CD4+ T-cell number decreases in rheumatoid patients with clinical response to rituximab.
Rheumatol Int
; 35(9): 1571-3, 2015 Sep.
Article
in En
| MEDLINE
| ID: mdl-26024733
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Arthritis, Rheumatoid
/
CD4-Positive T-Lymphocytes
/
Antirheumatic Agents
/
Rituximab
Type of study:
Observational_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Rheumatol Int
Year:
2015
Type:
Article